Free Trial

On Holding Slips Into A More Comfortable Price Point 

On Holdings stock price , shoe

Key Points

  • On Holdings had a solid quarter marred only by FX headwinds that cut into the top and bottom lines. 
  • Analysts are on board with the name and see it moving higher this year. 
  • The results suggest solid performance from names like Lululemon and Nike. 
  • Five stocks we like better than ON.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Shares of On Holding NYSE: ON were down about 10% following the Q2 earnings release, but this was an opportunity to buy more shares, not cut losses. The company's results are a testament to execution that includes a lean into direct-to-consumer and digital and also suggest solid results from Lululemon NASDAQ: LULU and Nike NYSE: NKE.

The only bad news is that FX headwinds cut into the bottom line, but that can be overlooked, given the company's growth trajectory and leverage. The takeaway is that shares are trading at the lowest level in nearly 2 months but are still above critical support and moving consistently with this year's uptrend

On Holdings: Growth Slows, But Guidance Is Raised 

On Holdings is experiencing a slowdown in growth but still outperforms the consensus estimates. The company reported CHF 444.3 million in revenue, an increase of 52.3% compared to last year, which beat the Marketbeat.com consensus on an adjusted basis. Sales are up 60% on an FXN basis, with DTC up 54.7% to outpace Wholesale by 370 basis points. 

DTC, the higher-margin channel, is up to 36.8% of the revenue and growing with strength seen in all regions and categories. Asia led regionally with growth of 90%, followed by 60% in the Americas and 29% in Europe. Shoes, the core business, led on a product basis with a growth of 53%. Even so, apparel and accessories were strong, with growth of 46% and 45.5%. 

The margin was aided by sales leverage, product mix, and full-price selling in the DTC channels. This led to a 440 basis point improvement in gross margin, adjusted EBITDA nearly doubled, and positive net income was achieved. The only bad news is that CHF 0.04 in earnings is down on a YOY basis and below consensus due to FX headwinds. 

The company raised guidance because of the Q2 strength and perceived momentum for H2. The new revenue target is CHF 1.76 billion, which implies full-year growth of 44% and 2nd half growth near 30%. This is slightly below the Marketbeat.com consensus estimate but may not be comparable because of currency fluctuations.

The Analysts Are On Board With On Holdings 

There are 16 analysts with current ratings for On Holdings, a significant figure showing a moderate conviction from the sell-side community. They peg the stock at Moderate Buy and have maintained that rating for at least the last 12 months. More importantly, the price target is trending higher than last year, last quarter, and last month. The price target is now above the price action, but that isn't the critical detail.

The critical point is that the previous price target set below consensus was in early April 2023. The 11 revisions that have come out since then are all well-above the consensus and have the market trading closer to $40. That's about 30% above the newly-discounted price action. 

On Holdings trades at a relatively high 55X earnings, compared to peers like Nike and Lululemon, which trade at 29X and 32X their earnings. They aren't growing as fast as On Holdings but are more established and do not have the same FX headwinds. This fact may weigh on prices in the near term, but the 2023 uptrend remains intact. 

Lululemon reports at the end of August, Nike in mid-September, and Nike at least has set cautious guidance. That could set it up for a substantial earnings beat when it reports. Twelve analysts have lowered targets recently, and none have raised them, so the bar could be set low. 

Price action in ONON fell double-digits following the release but appears to have found support above the 150-day moving average. This is consistent with critical levels associated with the post-IPO price action and 2023 reversal. Assuming these levels hold as support, this stock should begin to consolidate soon and prepare for a rally that could begin later this year or early in 2024. 

ONON stock chart

Should You Invest $1,000 in ON Right Now?

Before you consider ON, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ON wasn't on the list.

While ON currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Thomas Hughes
About The Author

Thomas Hughes

Contributing Author

Technical and Fundamental Analysis, S&P 500, Retail and Consumer Sectors, Dividends

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
lululemon athletica (LLL)N/AC$0.00NaNN/AN/AN/A
lululemon athletica (LULU)
4.7604 of 5 stars
$219.430.3%N/A14.87Moderate Buy$335.91
NIKE (NKE)
4.3856 of 5 stars
$76.271.1%2.10%35.31Moderate Buy$77.15
ON (ONON)
3.734 of 5 stars
$50.771.6%N/A72.52Moderate Buy$64.00
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines